Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2026-05-07 @ 3:21 AM
Study NCT ID:
NCT01571206
Status:
COMPLETED
Last Update Posted:
2013-07-31
First Post:
2012-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1
Sponsor:
Celltrion
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CT-P13 1.3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None